BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21289296)

  • 1. A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis.
    Sinha S; Roy S; Reddy BS; Pal K; Sudhakar G; Iyer S; Dutta S; Wang E; Vohra PK; Roy KR; Reddanna P; Mukhopadhyay D; Banerjee R
    Mol Cancer Res; 2011 Mar; 9(3):364-74. PubMed ID: 21289296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.
    Shrivastava A; Kuzontkoski PM; Groopman JE; Prasad A
    Mol Cancer Ther; 2011 Jul; 10(7):1161-72. PubMed ID: 21566064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells.
    Qi W; Sun M; Kong X; Li Y; Wang X; Lv S; Ding X; Gao S; Cun J; Cai C; Wang X; Chen J; Yin A; Yang Q
    Oncotarget; 2016 May; 7(18):26003-15. PubMed ID: 27027343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells.
    Yu X; Li R; Shi W; Jiang T; Wang Y; Li C; Qu X
    Biomed Pharmacother; 2016 Feb; 77():37-44. PubMed ID: 26796263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines.
    Zhang J; Riby JE; Conde L; Grizzle WE; Cui X; Skibola CF
    BMC Complement Altern Med; 2016 May; 16():151. PubMed ID: 27234961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer.
    Jinka S; Rachamalla HK; Bhattacharyya T; Sridharan K; Sekhar Jaggarapu MMC; Yakati V; Banerjee R
    Biomed Mater; 2021 Feb; 16(2):024105. PubMed ID: 33434900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo.
    Ribas R; Pancholi S; Guest SK; Marangoni E; Gao Q; Thuleau A; Simigdala N; Polanska UM; Campbell H; Rani A; Liccardi G; Johnston S; Davies BR; Dowsett M; Martin LA
    Mol Cancer Ther; 2015 Sep; 14(9):2035-48. PubMed ID: 26116361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of autophagy stimulate molecular iodine-induced apoptosis in hormone independent breast tumors.
    Singh P; Godbole M; Rao G; Annarao S; Mitra K; Roy R; Ingle A; Agarwal G; Tiwari S
    Biochem Biophys Res Commun; 2011 Nov; 415(1):181-6. PubMed ID: 22027149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis.
    L H Weischenfeldt K; Kirkegaard T; Rasmussen BB; Giobbie-Hurder A; Jensen MB; Ejlertsen B; Lykkesfeldt AE
    Acta Oncol; 2017 Sep; 56(9):1161-1167. PubMed ID: 28488912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics.
    Brueggemeier RW; Bhat AS; Lovely CJ; Coughenour HD; Joomprabutra S; Weitzel DH; Vandre DD; Yusuf F; Burak WE
    J Steroid Biochem Mol Biol; 2001 Aug; 78(2):145-56. PubMed ID: 11566439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.
    Lee JY; Won HY; Park JH; Kim HY; Choi HJ; Shin DH; Kang JH; Woo JK; Oh SH; Son T; Choi JW; Kim S; Kim HY; Yi K; Jang KS; Oh YH; Kong G
    J Clin Invest; 2015 May; 125(5):1801-14. PubMed ID: 25822021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
    Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
    Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.
    Jordan VC; Fan P; Abderrahman B; Maximov PY; Hawsawi YM; Bhattacharya P; Pokharel N
    Discov Med; 2016 May; 21(117):411-27. PubMed ID: 27355337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.
    Busch S; Sims AH; Stål O; Fernö M; Landberg G
    Cancer Res; 2015 Apr; 75(7):1457-69. PubMed ID: 25833830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
    Wei T; Xiaojun X; Peilong C
    Biomed Pharmacother; 2020 Jan; 121():109139. PubMed ID: 31707337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
    Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
    J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor.
    Choi S; Lim MH; Kim KM; Jeon BH; Song WO; Kim TW
    Toxicol Appl Pharmacol; 2011 Dec; 257(2):165-73. PubMed ID: 21933677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.